SEC Form 4 · accession 0001209191-17-051481
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jorma Routti
Director
Period of report
Aug 31, 2017
Accepted (ET)
Sep 5, 2017 · 9:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 31, 2017 | M | 6,000 | $3.60 | A | 133,840 | D | |
| Common StockF1 | Aug 31, 2017 | S | 6,000 | $46.78 | D | 127,840 | D | |
| Common Stock | Sep 1, 2017 | M | 6,000 | $3.60 | A | 133,840 | D | |
| Common StockF1 | Sep 1, 2017 | S | 6,000 | $47.93 | D | 127,840 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $3.60 | Aug 31, 2017 | M | 6,000 | D | — | Mar 11, 2019 | Common Stock | 6,000 | 6,000 | D |
| Stock Option (Right to Buy)F2 | $3.60 | Sep 1, 2017 | M | 6,000 | D | — | Mar 11, 2019 | Common Stock | 6,000 | 0 | D |
Explanation of responses
- F1Shares sold pursuant to a 10b5-1 plan.
- F2Fully vested.